EN
HI

ALKEM LABORATORIES Share price

ALKEM

HealthcareLarge

5260.5

113.50 (-2.11%)
NSE
BSE
Last updated on 22 May, 2025 | 12:40 IST
BUYSELL
Today's High

5388.00

Today's Low

5237.50

52 Week Low

4407.05

52 Week High

6439.90

The current prices are delayed, login to your account for live prices

Alkem Laboratories Chart

ALKEM LABORATORIES Fundamentals

P/E Ratio

29.86

P/B Ratio

5.3

Div. Yield

0.74

Sector P/E

29.87

Sector P/B

3.81

Sec. Div. Yield

0.52

ALKEM LABORATORIES Resistance and Support

Pivot 5343

Resistance

First Resistance

5431

Second Resistance

5488

Third Resistance

5576

Support

First Support

5286

Second Support

5198

Third Support

5141

ALKEM LABORATORIES Futures & Options

ALKEM-EQ

5260.5

-113.5 (-2.11%)

ALKEM LABORATORIES Option Chain

View Price, OI, Greeks & More...
View Allee

29MAY25

5236

-146.00 (2.71%)

26JUN25

5235

-149.00 (2.77%)

31JUL25

5299

-77.00 (1.43%)

ALKEM|29MAY25 CE 5250.00

90.85

-8985 (-49.72%)

ALKEM|29MAY25 PE 5300.00

132

6300 (91.3%)

ALKEM LABORATORIES Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    55.13%

    Mutual Fund

    14.97%

    Insurance

    3.2%

    Foreign Institutional Investors

    9.4%

    Domestic Institutional Investors

    1.26%

    Retail

    16.05%

    Others

    -0.01%

    Total Promoters
    MAR '25
    55.13%

    ALKEM LABORATORIES Corporate Actions

    DateAgenda
    2025-05-29Audited Results & Final Dividend
    2025-02-14-
    2025-02-07Quarterly Results & Interim Dividend
    DateEvent TypeAgenda
    2025-05-29Board MeetingAudited Results & Final Dividend
    2025-02-14Dividend-
    2025-02-07Board MeetingQuarterly Results & Interim Dividend

    ALKEM LABORATORIES News

    Cipla, Alkem Laboratories in final lap to buy SMT

    Oct 16 2024 05:32:05

    Cipla, Alkem Laboratories in final lap to buy SMT

    Oct 16 2024 05:32:00
    Read More

    About ALKEM LABORATORIES AboutThe

    NSE : 11703  
    BSE : 539523  
    ISIN : INE540L01014  

    The Company was incorporated as a private limited company ?Alkem Laboratories Private Limited? on August 81973 at Patna under the Companies Act 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act 1956 on October 26 1988. Pursuant to the Company passing a resolution under section 21 of Companies Act 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21 2001 the name of the Company was changed to ?Alkem Laboratories Limited? with effect from October 26 1988. the registered office was originally located at ?Exhibition Road Patna ? 800 001 Bihar India?. the Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra as approved by a special resolution at its extra-ordinary general meeting held on January 29 2007. The Company Law Board Eastern Region Bench at Kolkata passed an order dated July 30 2007 whereby it confirmed the alteration of the situation clause in the Memorandum of Association from the State of Bihar to the State of Maharashtra. Pursuant to the order the registered office of the Company was shifted to ?Alkem House Senapati Bapat Marg Lower Parel Mumbai ? 400 013 Maharashtra India? with effect from August 2 2007.Major Events :1973-Incorporation of the Company. 1978-the Company established its first plant at Taloja Maharashtra. 1988-the Company became a deemed public limited company. 1992-the Company established its manufacturing facility in Mandwa Maharashtra. This facility was converted into an API facility in 2005. 1998-the Company established its Kachigam manufacturing facility in Gujarat. 2001-Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company. 2002-the Company established its Amaliya manufacturing facility in Gujarat. 2003-the Company set up its research and development facility at Taloja Maharashtra. 2005-the Company established its manufacturing facility in Baddi Himachal Pradesh. 2006-the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1000 million in terms of domestic sales in India (Source: IMS Research) 2007-the Company established its manufacturing facility in Kumrek Sikkim. -the Company filed its first ANDA in the United States for the drug Amlodipine. -the Company shifted its Registered Office from Patna Bihar to Mumbai Maharashtra. 2009-the Company acquired Pharmacor a generic pharma company in Australia. 2010-the Company acquired The PharmaNetwork LLC the holding company of Ascend Laboratories LLC. 2011-the Company acquired Enzene Bio sciences Limited. 2012-the Company acquired an API manufacturing facility in the United States. 2014-the Company acquired the Clindac. 2015-the Company acquired a formulation manufacturing facility in the United States. Awards and achievements: 2002-the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India?s Most Esteemed Pharmaceutical Company'2004-the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004 2005-the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005 2009-the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India supported by Ministry of Commerce and Industry GOI -the Company received the certificate of appreciation in the category of ?Formulation Experts? by the Pharmaceuticals Export Promotion Council of India supported by Ministry of Commerce and Industry GOI 2013-the Company was awarded the India?s most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013 2014-the Product ?Clavam? was awarded as the ? Brand of the Year? at the AWACS Award 2014

    ALKEM LABORATORIES Management

    NamePosition
    Mr. Basudeo N Singh Executive Chairman
    Mr. Sandeep Singh Managing Director
    Mrs. Madhurima Singh Executive Director
    Mr. Srinivas Singh Executive Director
    Mr. Mritunjay Kumar Singh Executive Director
    Read More

    ALKEM LABORATORIES FAQs

    ALKEM LABORATORIES शेयर का खरीद मूल्य 5260.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    ALKEM LABORATORIES शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    ALKEM LABORATORIES शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 29.86 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    ALKEM LABORATORIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.3 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    ALKEM LABORATORIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.81 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    ALKEM LABORATORIES का मार्केट कैप 64254.23 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    ALKEM LABORATORIES शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 6439.90 और 4407.05 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    ALKEM LABORATORIES Share Key Metrics

    Volume
    1.18 L
    Market Cap
    64254.23 CR
    LTQ@LTP
    4@5260.50
    ATP
    5312.66
    Var Margin
    13.52 %
    Circuit Range
    4837-5911
    Delivery %
    50.81 %
    Value
    62.85 CR
    ASM/GSM
    No
    Market Lot
    1